Expert Opinion on Drug Safety

Top Research Topics at Expert Opinion on Drug Safety?

The main research concerns discussed in the journal are Internal medicine, Adverse effect, Intensive care medicine, Pharmacology and Drug. Some problems in Internal medicine that were presented in it overlapped with concepts under Gastroenterology, Surgery, Oncology and Cardiology. It explores topics in Oncology which can be helpful for research in disciplines like Cancer, Breast cancer and Chemotherapy.

The work on Adverse effect tackled in Expert Opinion on Drug Safety brings together disciplines like Anesthesia, Randomized controlled trial and Immunology. While work presented in the journal provided substantial information on Intensive care medicine, it also covered topics in Observational study, Disease and MEDLINE. The Pharmacovigilance study tackled is a key component of adjacent topics in the area of Drug reaction.

• Internal medicine (32.80%)
• Adverse effect (26.54%)
• Intensive care medicine (25.02%)

What are the most cited papers published in the journal?

• Clinical consequences of polypharmacy in elderly (810 citations)
• Paclitaxel: a review of adverse toxicities and novel delivery strategies. (258 citations)
• Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis (207 citations)

Research areas of the most cited articles at Expert Opinion on Drug Safety:

The most cited papers are mainly concerned with subjects like Pharmacology, Adverse effect, Internal medicine, Intensive care medicine and Drug. The Internal medicine research presented in the journal articles focuses mostly on Oncology and, on occasion, topics in Breast cancer and Cancer. While Intensive care medicine is the key highlight in the most cited articles, thet also covered some subjects on MEDLINE and Alternative medicine.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Cancer

The previous edition focused in particular on these issues:

Expert Opinion on Drug Safety is organized to address concerns in the fields of Internal medicine, Adverse effect, Intensive care medicine, Drug and Oncology. The Pharmacovigilance, Meta-analysis and Randomized controlled trial studies presented in Expert Opinion on Drug Safety fall under the field of Internal medicine, but it also has connections to other fields such as In patient. It addresses concerns in Adverse effect which are intertwined with other disciplines, such as Placebo, Clinical trial, Side effect and Drug class.

While Expert Opinion on Drug Safety focused on Intensive care medicine, it was also able to explore topics like Antibiotics, Treatment options, Pharmacotherapy, Disease and Coronavirus disease 2019 (COVID-19). The journal connects the study in Drug with the closely related area of Observational study. In the journal, Cancer, Tyrosine-kinase inhibitor, Quality of life and Chemotherapy are investigated in conjunction with one another to address concerns in Oncology research.

The most cited articles from the last journal are:

• Tafenoquine: a toxicity overview. (5 citations)
• Adverse drug reactions in elderly: a five-year review of spontaneous reports to the Portuguese Pharmacovigilance System. (4 citations)
• Deprescribing in migraine (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Expert Opinion on Drug Safety (based on the number of publications) are:

• Icilio Cavero (22 papers) absent at the last edition,
• Peter V. Giannoudis (15 papers) absent at the last edition,
• Liberata Sportiello (13 papers) absent at the last edition,
• Concetta Rafaniello (12 papers) absent at the last edition,
• Francesco Rossi (12 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Opinion on Drug Safety (based on the number of publications) are:

• University of Milan (39 papers) published 4 papers at the last edition, 2 more than at the previous edition,
• Seconda Università degli Studi di Napoli (26 papers) published 1 paper at the last edition the same number as at the previous edition,
• Harvard University (25 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Sapienza University of Rome (25 papers) published 4 papers at the last edition, 1 more than at the previous edition,
• University of Bologna (22 papers) published 3 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.56% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 15.20% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 9.36% of all publications and 64.33% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Drug Safety and Pharmacology

An understanding of the disciplines covered in the Expert Opinion on Drug Safety such as internal medicine, intensive care medicine and pharmacology among others, provide extensive scope for a variety of potential careers. For instance, pursuing a career in the healthcare industry such as registered nursing can be a viable choice for individuals equipped with a strong foundational knowledge in these disciplines. Colorado, being a state with a significant demand for highly skilled registered nurses can provide a suitable option. It is important to note that there are specific requirements and qualifications to become a registered nurse in the Colorado region. If you are interested to explore this career further, you might want to consider reviewing our guide on how to become a registered nurse in Colorado online.

Beyond this, the knowledge accrued from the study of drug safety and pharmacology can be applied towards a multitude of roles in clinical research, drug approvals, civil services, academia, and industries related to pharmaceuticals and biotechnologies. The abundance of opportunities underline the extensive scope and influence of an educational or research background in drug safety and pharmacology.